411 related articles for article (PubMed ID: 16777482)
1. PPARs and other nuclear receptors in inflammation.
Rizzo G; Fiorucci S
Curr Opin Pharmacol; 2006 Aug; 6(4):421-7. PubMed ID: 16777482
[TBL] [Abstract][Full Text] [Related]
2. Integration of metabolism and inflammation by lipid-activated nuclear receptors.
Bensinger SJ; Tontonoz P
Nature; 2008 Jul; 454(7203):470-7. PubMed ID: 18650918
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.
Sugden MC; Holness MJ
Biochem Soc Trans; 2008 Oct; 36(Pt 5):891-900. PubMed ID: 18793157
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptors in macrophages: a link between metabolism and inflammation.
Szanto A; Roszer T
FEBS Lett; 2008 Jan; 582(1):106-16. PubMed ID: 18022390
[TBL] [Abstract][Full Text] [Related]
5. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
Chinetti-Gbaguidi G; Staels B
Biochim Biophys Acta; 2009 Jun; 1791(6):486-93. PubMed ID: 19416654
[TBL] [Abstract][Full Text] [Related]
6. PPARs as therapeutic targets in cardiovascular disease.
van Bilsen M; van Nieuwenhoven FA
Expert Opin Ther Targets; 2010 Oct; 14(10):1029-45. PubMed ID: 20854178
[TBL] [Abstract][Full Text] [Related]
7. Nuclear receptor signaling in macrophages.
Valledor AF; Ricote M
Biochem Pharmacol; 2004 Jan; 67(2):201-12. PubMed ID: 14698033
[TBL] [Abstract][Full Text] [Related]
8. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis.
Li AC; Glass CK
J Lipid Res; 2004 Dec; 45(12):2161-73. PubMed ID: 15489539
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial roles of nuclear receptors in inflammation and immunity.
Glass CK; Ogawa S
Nat Rev Immunol; 2006 Jan; 6(1):44-55. PubMed ID: 16493426
[TBL] [Abstract][Full Text] [Related]
10. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
[TBL] [Abstract][Full Text] [Related]
11. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
[TBL] [Abstract][Full Text] [Related]
12. Modulation of PPAR activity via phosphorylation.
Burns KA; Vanden Heuvel JP
Biochim Biophys Acta; 2007 Aug; 1771(8):952-60. PubMed ID: 17560826
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance.
Huang W; Glass CK
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1542-9. PubMed ID: 20631355
[TBL] [Abstract][Full Text] [Related]
14. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
15. Functional Regulation of PPARs through Post-Translational Modifications.
Brunmeir R; Xu F
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
[TBL] [Abstract][Full Text] [Related]
16. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.
Rigamonti E; Chinetti-Gbaguidi G; Staels B
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1050-9. PubMed ID: 18323516
[TBL] [Abstract][Full Text] [Related]
17. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
Ricote M; Valledor AF; Glass CK
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):230-9. PubMed ID: 14592855
[TBL] [Abstract][Full Text] [Related]
18. PPARs and LXRs: atherosclerosis goes nuclear.
Barish GD; Evans RM
Trends Endocrinol Metab; 2004; 15(4):158-65. PubMed ID: 15109614
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
Beaven SW; Tontonoz P
Annu Rev Med; 2006; 57():313-29. PubMed ID: 16409152
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis.
Hansen MK; Connolly TM
Curr Opin Investig Drugs; 2008 Mar; 9(3):247-55. PubMed ID: 18311660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
